Enjoying this blog? Check out the rest of the Health & Wellness Channel 
According to a study that appeared online in the January 22 issue of Lancet Oncology, patients taking Nexavar® (sorafenib) need to be carefully monitored and treated.
In clinical testing, Nexavar improved overall survival by 44 percent among people with HCC. Median overall survival was 10.7 months among those treated with the drug, versus 7.9 months among […]
Compared to either agent alone, the combination of interferon alpha and sorafenib has been found to work better for patients with renal cell carcinoma –the common form of kidney cancer.
Such were the findings of a pilot study led by Duke University Comprehensive Cancer Center researchers.
According to Jared Gollob, M.D., an oncologist at Duke and lead […]
Wyeth Pharmaceuticals’ new kidney cancer drug Torisel™ (temsirolimus) has recently been approved by the FDA for the treatment of renal cell carcinoma - a type of advanced kidney cancer.
Torisel™ is an enzyme inhibitor (mTOR inhibitor to be exact) whose FDA approval came following results of prolonged survival in renal cell carcinoma patients.
According to Dr. Steven […]
Regardless of the type of alcoholic beverage (beer wine, liquor) - in both men and women - drinking at least an average of one alcoholic beverage a day was found associated with a 30% reduction in renal cancer risk.
Such is the result of an analysis of 12 prospective studies of alcohol consumption among renal cancer […]
Cell renal carcinoma is the most common and aggressive type of renal tumor or kidney cancer.
Imaging with Positron Emission Tomography (PET) using a radiolabeled monoclonal antibody G250 (originally developed as a potential therapeutic agent) can accurately identify cell renal carcinoma that needs surgery.
This was based on findings of a new study done by researchers at […]
The nonsurgical image-guided treatment of kidney tumors — cryoablation - - is as effective as the laparoscopic technique in viable candidates.
Such is the research finding recently reported at the Society of Interventional Radiology’s 32nd Annual Scientific Meeting.
The comparative trial shows that percutaneous cryoablation results in a slightly lower recurrence rate of the tumor, a shorter […]
According to a new study published online October 20, 2006 in the International Journal of Cancer (the official journal of the International Union Against Cancer or UICC), there is a significant link between high bread consumption and renal cell carcinoma and that eating a lot of pasta and rice may also raise the risk, while eating […]
Removing the entire kidney is the gold standard for 40 years in the treatment of a single, small tumor in the kidney.
A retrospective study appearing in the September issue of The Lancet Oncology suggests that such practice needs to be re-evaluated.
Urologists at the Memorial Sloan-Kettering Cancer Center (MSKCC) and their colleagues reported that with advances in […]
Metastatic renal cell carcinoma (mRCC) or advanced kidney cancer’s initial therapy is the current standard cytokine treatment. In a new study from Memorial Sloan-Kettering Cancer Center, the drug sunitinib malate (Sutentｮ) was found more effective than the current standard treatment in treating advanced kidney cancer.
“This drug has shown more activity as a single agent against […]
Cancer therapies, healing, and society.
Written by Gloria Gamat [email] for b5media.
A Dozen Steps
A Hearty Life
Alzheimer's Notes
Astronomy Buff
Autism Vox
Baldiness
Breaking the Mirror
Breastfeeding 1-2-3
Cancer Commentary
Daily Tomorrow
Diabetes Notes
Eating Fabulous
Fertility Notes
Genetics & Health
Health and Men
Healthbolt
Help My Hurt
Kids Health Notes
Lively Women
Mental Health Notes
Pink Ribbon Review
Tales of CFS
Veggie Chic
Weighting Line
Recent Comments